Imaginal Exposure II Study: In-Vivo

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

December 13, 2020

Study Completion Date

October 1, 2022

Conditions
Eating DisorderAnorexia NervosaBulimia NervosaExposure
Interventions
BEHAVIORAL

imaginal exposure therapy

All participants will complete the same arm, which is ten sessions of imaginal exposure across a ten week time period. Each session is separated by 1 week.

Trial Locations (1)

40205-1016

Eating Anxiety Treatment Laboratory and Clinic, Louisville

All Listed Sponsors
lead

University of Louisville

OTHER

NCT03934697 - Imaginal Exposure II Study: In-Vivo | Biotech Hunter | Biotech Hunter